Peptides DB
Research-centric peptide and protocol reference hub

Tesa IPA Protocol (Tesa-IPA) record · updated 20h ago

Muscle & body compMetabolic & appetiteGrade B · human evidenceResearch use only
All 4 studiesJump to the evidenceCompare
What is Tesa IPA Protocol (Tesa-IPA) used for?

Tesamorelin + Ipamorelin GH Secretagogue Blend

Primarily researched for · Muscle & body comp

Development stage

where Tesa IPA Protocol (Tesa-IPA) sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 16 registered trials. It describes the research record, not a recommendation.

Identity
NameTesa IPA Protocol (Tesa-IPA)
Chain length
Molecular weight
Formula
Structure type
ClassMuscle
Research levelLimited Research
Discovered byCurated master list · 2026
Pharmacology
Mechanism
Route
Half-life
Time to peak
Duration
Extraction confidence
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 28, 2026. How this works →
Research stats
Total studies4
Human / animal / cellular2 / 1 / 1
Highest trial phasePreclinical
Years covered2021–2026
Latest study1mo ago
Publication history
20212026
Research funding
no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work
Community reports
Positive Neutral Negative
Records

Study register

4 rowsOpen in the library →
StudyTypeYearSummary depth
A microfluidic approach to rapid sperm recovery from heterogeneous cell suspensions.
Finding> 96% recovery of sperm cells in less than 5 min.
In vitro2021Partial text0.50
An NK-like CAR T cell transition in CAR T cell dysfunction.
TakeawayThis study highlights the transition of CAR T cells to an NK-like state in pancreatic cancer, suggesting that targeting specific transcription factors may improve CAR T cell function, though specific outcomes are not detailed.
Human2021Title only0.30
Structural, mechanistic, and physiological insights into phospholipase A-mediated membrane phospholipid degradation in <i>Pseudomonas aeruginosa</i>.
FindingNot reported in abstract.
Animal2022Full text read0.70
Cortical markers of PAS-induced long-term potentiation and depression in the motor system: A TMS-EEG Registered Report.
FindingNot reported in abstract.
Human2026Full text read0.80

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Tesa IPA Protocol (Tesa-IPA) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Tesa IPA Protocol (Tesa-IPA) is discussed should be drawn from it.